July 25, 2017 – By Winifred Garcia
Genesis Healthcare Inc (NYSE:GEN) Ratings Coverage
Among 5 analysts covering Genesis Healthcare (NYSE:GEN), 1 have Buy rating, 2 Sell and 2 Hold. Therefore 20% are positive. Genesis Healthcare had 12 analyst reports since August 10, 2015 according to SRatingsIntel. RBC Capital Markets upgraded Genesis Healthcare Inc (NYSE:GEN) rating on Monday, August 10. RBC Capital Markets has “Sector Perform” rating and $10.0 target. RBC Capital Markets maintained the shares of GEN in report on Monday, June 12 with “Hold” rating. The firm has “Neutral” rating given on Monday, November 9 by UBS. The stock of Genesis Healthcare Inc (NYSE:GEN) has “Sell” rating given on Monday, February 8 by UBS. The firm earned “Sector Perform” rating on Monday, November 21 by RBC Capital Markets. RBC Capital Markets maintained it with “Outperform” rating and $3 target in Monday, May 16 report. The stock of Genesis Healthcare Inc (NYSE:GEN) earned “Outperform” rating by RBC Capital Markets on Tuesday, January 26. The stock of Genesis Healthcare Inc (NYSE:GEN) earned “Neutral” rating by Bank of America on Tuesday, January 26. As per Monday, May 16, the company rating was downgraded by Bank of America. The stock of Genesis Healthcare Inc (NYSE:GEN) earned “Neutral” rating by Susquehanna on Tuesday, January 26. Below is a list of Genesis Healthcare Inc (NYSE:GEN) latest ratings and price target changes.
17/07/2017 Broker: RBC Capital Markets Rating: Hold New Target: $3.0000 Maintain
12/06/2017 Broker: RBC Capital Markets Rating: Hold New Target: $3.0000 Maintain
06/07/2017 Broker: Cantor Fitzgerald Rating: Overweight New Target: $7 Initiates Coverage On
About 160,187 shares traded. Genesis Healthcare Inc (NYSE:GEN) has risen 29.94% since July 25, 2016 and is uptrending. It has outperformed by 13.24% the S&P500.
Genesis Healthcare, Inc. is a holding firm that provides post-acute care. The company has market cap of $236.65 million. The Firm operates through three divisions: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services. It currently has negative earnings. As of December 31, 2016, the Company offered inpatient services through its network of 499 skilled nursing and assisted/senior living facilities across 34 states, consisting of 473 skilled nursing facilities and 26 stand-alone assisted/senior living facilities.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.